Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
Titel:
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
Auteur:
Kennedy, Oliver John Glassee, Nina Kicinski, Michal Blank, Christian U. Long, Georgina V. Atkinson, Victoria G. Dalle, Stéphane Haydon, Andrew M. Meshcheryakov, Andrey Khattak, Adnan Carlino, Matteo S. Sandhu, Shahneen Larkin, James Puig, Susana Ascierto, Paolo A. Rutkowski, Piotr Schadendorf, Dirk Boers-Sonderen, Marye Giacomo, Anna Maria Di van den Eertwegh, Alfonsus J.M. Grob, Jean-Jacques Gutzmer, Ralf Jamal, Rahima van Akkooi, Alexander C.J. Gandini, Sara Buhrer, Emanuel Suciu, Stefan Robert, Caroline Eggermont, Alexander M.M. Mandala, Mario Lorigan, Paul Valpione, Sara